Number of the records: 1  

Continuous Activity Assay for HDAC11 Enabling Reevaluation of HDAC Inhibitors

  1. 1.
    SYSNO ASEP0579099
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleContinuous Activity Assay for HDAC11 Enabling Reevaluation of HDAC Inhibitors
    Author(s) Kutil, Z. (CZ)
    Mikešová, J. (CZ)
    Zessin, M. (DE)
    Meleshin, M. (DE)
    Nováková, Z. (CZ)
    Alquicer, Glenda (UMG-J)
    Kozikowski, A. (US)
    Sippl, W. (DE)
    Bařinka, C. (CZ)
    Schutkowski, M. (DE)
    Number of authors10
    Source TitleACS Omega. - : American Chemical Society - ISSN 2470-1343
    Roč. 4, č. 22 (2019), s. 19895-19904
    Number of pages10 s.
    Languageeng - English
    CountryUS - United States
    Keywordshistone deacetylase inhibitors ; sir2 family ; posttranslational modifications ; fluorescent-probe ; peptide arrays ; in-vitro ; substrate-specificity ; metabolic-regulation ; fluorogenic probe ; activity profiles
    OECD categoryBiochemistry and molecular biology
    R&D ProjectsED1.1.00/02.0109 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Method of publishingOpen access
    Institutional supportUMG-J - RVO:68378050
    UT WOS000499133200042
    EID SCOPUS85075614812
    DOI10.1021/acsomega.9b02808
    AnnotationHistone deacetylase 11 (HDAC11) preferentially removes fatty acid residues from lysine side chains in a peptide or protein environment. Here, we report the development and validation of a continuous fluorescence-based activity assay using an internally quenched TNF alpha-derived peptide derivative as a substrate. The threonine residue in the +1 position was replaced by the quencher amino acid 3'-nitro-L-tyrosine and the fatty acyl moiety substituted by 2-aminobenzoylated 11-aminoundecanoic acid. The resulting peptide substrate enables fluorescence-based direct and continuous readout of HDAC11-mediated amide bond cleavage fully compatible with high-throughput screening formats. The Z'-factor is higher than 0.85 for the 15 mu M substrate concentration, and the signal-to-noise ratio exceeds 150 for 384-well plates. In the absence of NAD(+), this substrate is specific for HDAC 11. Reevaluation of inhibitory data using our novel assay revealed limited potency and selectivity of known HDAC inhibitors, including Elevenostat, a putative HDAC11-specific inhibitor.
    WorkplaceInstitute of Molecular Genetics
    ContactNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Year of Publishing2024
    Electronic addresshttps://pubs.acs.org/doi/10.1021/acsomega.9b02808
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.